A CML, or Chronic Myeloid Leukemia, is a type of cancer that affects the bone marrow and white blood cells.
Understanding CML
Chronic Myeloid Leukemia (CML), also known as chronic myelogenous leukemia, is characterized by the slow and prolonged development of cancerous cells. Here's a more detailed breakdown:
Key Features of CML
- Bone Marrow Impact: CML primarily affects the bone marrow, where blood cells are produced.
- White Blood Cell Abnormalities: The cancer involves the uncontrolled growth of abnormal white blood cells.
- Slow Progression: Unlike some other forms of leukemia, CML progresses slowly over several years.
- Age Factor: Though it can be diagnosed at any age, CML is more common in individuals aged 65 and older.
- Treatable Condition: The good news is that CML is typically treatable with various medical approaches.
How CML Develops
CML develops when the bone marrow produces an excessive amount of abnormal white blood cells. These abnormal cells don't function correctly and can crowd out the healthy cells, leading to the symptoms associated with leukemia.
Treatment and Management
Because CML develops slowly, treatment can be started to help control the number of abnormal white blood cells and minimize the disease's symptoms and progression.
Comparison of CML
| Feature | Description |
|---|---|
| Type of Cancer | Affects the bone marrow and white blood cells. |
| Progression | Develops slowly over several years. |
| Typical Age | More common in people 65 or over, but can occur at any age. |
| Treatment | Usually treatable, often with medications targeting the abnormal cells. |
